The five-day crackdown started Monday, focusing on I-95 in Halifax and Northampton counties, according to a Saturday news ...
Eli Lilly‘s stock fell 4.58% following weak trial results from Novo Nordisk’s obesity drug, shaking investor confidence in the sector. Despite the dip, Eli Lilly remains financially strong, with an ...
The Philippine government has told the United Nations (UN) that there has been a drop in illegal drugs use in the country during the administration of President Marcos. During the 68th session of the ...
Trevi Therapeutics (NASDAQ:TRVI) stock jumped about 40% premarket after its mid-stage trial for Haduvio, a potential treatment for chronic coughing, met its main goal. Haduvio, the company's ...
which is right in line with the semiglutide drugs. So, this is disappointing Wall Street. You saw on your screen just now, they stock down more than 8%, that's been consistent throughout the day.
Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of hypertension. The therapy, called lorundrostat, hit the primary endpoint of ...
Hims & Hers is shutting down the dermatology business it acquired four years ago, Business Insider has learned. On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer ...
Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally ...
Shares of Plus Therapeutics, Inc. PSTV were up a whopping 311.4% on March 6 after the company announced that the FDA has granted an Orphan Drug Designation (“ODD”) to its lead radiotherapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results